Omega Fund Management, LLC

BOSTON, MA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$125.2M2026 Q3
Positions10
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

Omega Fund Management, LLC reported 10 positions worth $125.2M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: NUVB (32.0%). Biggest move: reduce KMTS ($18.7M).

10 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 NUVBNuvation Bio$40.0M31.99%7,151,031——-31.4%
▸ 2 BCAXBicara Therapeutics$32.8M26.17%1,759,912——-46.2%
▸ 3 BBNXBeta Bionics$18.3M14.59%962,010——-19.9%
▸ 4 BBOTBridgeBio Oncology Therapeutics$13.5M10.78%3,289,661——-47.8%
▸ 5 KMTSKestra Medical Technologies$10.3M8.19%362,394——-1.1%
▸ 6 IMUXImmunic$4.0M3.20%430,180———
▸ 7 SANASana Biotechnology$2.5M1.97%843,750——-35.5%
▸ 8 IMAImageneBio$2.1M1.67%455,361——-24.7%
▸ 9EngeneenGene$1.8M1.40%876,357———
▸ 10 ODTXOdyssey Therapeutics$64.3K0.05%2,893———

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Omega Fund Management, LLC hold as of Q3 2026?

Omega Fund Management, LLC reported 10 positions worth $125.2M in its Q3 2026 13F filing. Largest positions: NUVB (32.0%), BCAX (26.2%), BBNX (14.6%), BBOT (10.8%) and KMTS (8.2%).

What did Omega Fund Management, LLC buy in Q3 2026?

New positions: IMUX.

What did Omega Fund Management, LLC sell in Q3 2026?

Reduced: KMTS, BBNX, NUVB and BCAX. Sold out entirely: ALMS.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.